πŸ‡ΊπŸ‡Έ FDA
Patent

US 10118938

Arsenoplatin anti-cancer agents

granted A61KA61K31/282A61K31/285

Quick answer

US patent 10118938 (Arsenoplatin anti-cancer agents) held by Northwestern University expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/282, A61K31/285, A61K31/29, A61K31/295